Udine Wealth Management Inc. Invests $925,000 in Oscar Health, Inc. (NYSE:OSCR)

Udine Wealth Management Inc. purchased a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) during the 3rd quarter, HoldingsChannel reports. The firm purchased 43,622 shares of the company’s stock, valued at approximately $925,000. Oscar Health accounts for about 0.7% of Udine Wealth Management Inc.’s holdings, making the stock its 27th biggest holding.

Other hedge funds have also recently modified their holdings of the company. Price T Rowe Associates Inc. MD raised its stake in Oscar Health by 153.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after buying an additional 2,409,160 shares in the last quarter. Iron Triangle Partners LP acquired a new stake in shares of Oscar Health during the 4th quarter worth $18,781,000. First Light Asset Management LLC boosted its position in Oscar Health by 117.3% in the 1st quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock valued at $31,265,000 after buying an additional 1,134,919 shares during the last quarter. Renaissance Technologies LLC grew its stake in Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after purchasing an additional 934,600 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in Oscar Health in the second quarter valued at approximately $14,716,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Down 1.1 %

Shares of OSCR opened at $18.28 on Wednesday. The company has a 50 day simple moving average of $19.00 and a two-hundred day simple moving average of $18.13. Oscar Health, Inc. has a 1 year low of $4.72 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market cap of $4.34 billion, a P/E ratio of -45.70, a price-to-earnings-growth ratio of 40.11 and a beta of 1.62.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The business had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company’s revenue was up 44.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.07) earnings per share. On average, equities analysts expect that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have issued reports on OSCR shares. Wells Fargo & Company lifted their price target on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 12th. Piper Sandler reissued an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. Finally, UBS Group assumed coverage on shares of Oscar Health in a research report on Monday. They set a “neutral” rating and a $23.00 target price on the stock. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $24.00.

Insider Activity at Oscar Health

In related news, insider Mario Schlosser sold 3,198 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction on Friday, September 6th. The stock was sold at an average price of $17.06, for a total transaction of $286,488.58. Following the sale, the executive vice president now owns 392,607 shares of the company’s stock, valued at $6,697,875.42. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 169,569 shares of company stock valued at $3,007,069. 25.11% of the stock is owned by insiders.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.